References
- Glass LF, Jaroszeski M, Gilbert R, Reintgen DS, Heller R. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol 1997; 37: 596-9. doi: 10.1016/S0190-9622(97)70178-6
- Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy – an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 2006; 4: 3-13. doi: 10.1016/j.ejcsup.2006.08.002
- Clover AJP, de Terlizzi F, Bertino G, Curatolo P, Odili J, Campana LG, et al. Electrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019). Eur J Cancer 2020; 138: 30-40. doi: 10.1016/j.ejca.2020.06.020
- Plaschke CC, Bertino G, McCaul JA, Grau JJ, de Bree R, Sersa G, et al. European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: results from the treatment of mucosal cancers. Eur J Cancer 2017; 87: 172-81. doi: 10.1016/j.ejca.2017.10.008
- Bertino G, Sersa G, De Terlizzi F, Occhini A, Plaschke CC, Groselj A, et al. European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: results of the treatment of skin cancer. Eur J Cancer 2016; 63: 41-52. doi: 10.1016/j.ejca.2016.05.001
- Kunte C, Letulé V, Gehl J, Dahlstroem K, Curatolo P, Rotunno R, et al. Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT. Br J Dermatol 2017; 176: 1475-85. doi: 10.1111/bjd.15340
- Campana LG, Quaglino P, de Terlizzi F, Mascherini M, Brizio M, Spina R, et al. Health-related quality of life trajectories in melanoma patients after electrochemotherapy: real-world insights from the INSPECT register. Acad Dermatol Venereol 2022; 36: 2352-63. doi: 10.1111/jdv.18456
- Matthiessen LW, Keshtgar M, Curatolo P, Kunte C, Grischke EM, Odili J, et al. Electrochemotherapy for breast cancer – results From the INSPECT database. Clin Breast Cancer 2018; 18: e909-17. doi: 10.1016/j.clbc.2018.03.007
- Di Prata C, Mascherini M, Ross AM, Silvestri B, Kis E, Odili J, et al. Efficacy of electrochemotherapy in breast cancer patients of different receptor status: the INSPECT experience. Cancers 2023; 15: 3116. doi: 10.3390/cancers15123116
- Bertino G, Muir T, Odili J, Groselj A, Marconato R, Curatolo P, et al. Treatment of basal cell carcinoma with electrochemotherapy: insights from the InspECT registry (2008-2019). Curr Oncol 2022; 29: 5324-37. doi: 10.3390/curroncol29080423
- Bertino G, Groselj A, Campana LG, Kunte C, Schepler H, Gehl J, et al. Electrochemotherapy for the treatment of cutaneous squamous cell carcinoma: The INSPECT experience (2008-2020). Front Oncol 2022;12: 951662. doi: 10.3389/fonc.2022.951662
- Campana LG, Kis E, Bottyán K, Orlando A, De Terlizzi F, Mitsala G, et al. Electrochemotherapy for advanced cutaneous angiosarcoma: a European register-based cohort study from the International Network for Sharing Practices of electrochemotherapy (InspECT). Int J Surg 2019; 72: 34-42. doi: 10.1016/j.ijsu.2019.10.013
- Sersa G, Mascherini M, Di Prata C, Odili J, de Terlizzi F, McKenzie GAG, et al. Outcomes of older adults aged 90 and over with cutaneous malignancies after electrochemotherapy with bleomycin: a matched cohort analysis from the InspECT registry. Eur J Surg Oncol 2021; 47: 902-12. doi: 10.1016/j. ejso.2020.10.037
- Spallek H, Bischoff P, Zhou W, de Terlizzi F, Jakob F, Kovàcs A. Percutaneous electrochemotherapy in primary and secondary liver malignancies – local tumor control and impact on overall survival. Radiol Oncol 2022; 56: 102-10. doi: 10.2478/raon-2022-0003
- Granata V, Fusco R, D′Alessio V, Simonetti I, Grassi F, Silvestro L, et al. Percutanous electrochemotherapy (ECT) in primary and secondary liver malignancies: a systematic review. Diagnostics 2023; 13: 209. doi: 10.3390/diagnostics13020209
- Tafuto S, von Arx C, De Divitiis C, Tracey Maura C, Palaia R, Albino V, et al. Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases. Int J Surg 2015; 21: S78-82. doi: 10.1016/j.ijsu.2015.04.095
- Campanacci L, Bianchi G, Cevolani L, Errani C, Ciani G, Facchini G, et al. Operating procedures for electrochemotherapy in bone metastases: results from a multicenter prospective study on 102 patients. Eur J Surg Oncol 2021; 47: 2609-17. doi: 10.1016/j.ejso.2021.05.004
- Deschamps F, Tselikas L, Yevich S, Bonnet B, Roux C, Kobe A, et al. Electrochemotherapy in radiotherapy-resistant epidural spinal cord compression in metastatic cancer patients. Eur J Cancer 2023;186: 62-8. doi: 10.1016/j.ejca.2023.03.012
- Kovács A, Bischoff P, Haddad H, Zhou W, Temming S, Schäfer A, et al. Long-term comparative study on the local tumour control of different ablation technologies in primary and secondary liver malignancies. J Pers Med 2022; 12: 430. doi: 10.3390/jpm12030430
- Gasljevic G, Edhemovic I, Cemazar M, Brecelj E, Gadzijev EM, Music MM, et al. Histopathological findings in colorectal liver metastases after elec-trochemotherapy. PLoS One 2017; 12: e0180709. doi: 10.1371/journal. pone.0180709
- Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 2016; 27: 1386-422. doi: 10.1093/annonc/mdw235
- Brloznik M, Boc N, Sersa G, Zmuc J, Gasljevic G, Seliskar A, et al. Radiological findings of porcine liver after electrochemotherapy with bleomycin. Radiol Oncol 2019; 53: 415-26. doi: 10.2478/raon-2019-0049
- Zmuc J, Gasljevic G, Sersa G, Edhemovic I, Boc N, Seliskar A, et al. Large liver blood vessels and bile ducts are not damaged by electrochemotherapy with bleomycin in pigs. Sci Rep 2019; 9: 3649. doi: 10.1038/s41598-019-40395-y1.
- Cornelis FH, Korenbaum C, Ben Ammar M, Tavolaro S, Nouri-Neuville M, Lotz JP. Multimodal image-guided electrochemotherapy of unresectable liver metastasis from renal cell cancer. Diagn Interv Imaging 2019; 100: 309-11. doi: 10.1016/j.diii.2019.01.001
- Edhemovic I, Brecelj E, Cemazar M, Boc N, Trotovsek B, Djokic M, et al. Intraoperative electrochemotherapy of colorectal liver metastases: a prospective phase II study. Eur J Surg Oncol 2020; 46: 1628-33. doi: 10.1016/j.ejso.2020.04.037
- Mali B, Gorjup V, Edhemovic I, Brecelj E, Cemazar M, Sersa G, et al. Electrochemotherapy of colorectal liver metastases – an observational study of its effects on the electrocardiogram. BioMed Eng OnLine 2015; 14(Suppl 3): S5. doi: 10.1186/1475-925X-14-S3-S5
- Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, et al. Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. Eur J Cancer Suppl 2006; 4: 14-25. doi: 10.1016/j. ejcsup.2006.08.003
- Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncologica 2018; 57: 874-82. doi: 10.1080/0284186X.2018.1454602
- Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47. doi: 10.1016/j.ejca.2008.10.026
- Dudeck O, Ricke J. Advances in regional chemotherapy of the liver. Expert Opin Drug Deliv 2011; 8: 1057-69. doi: 10.1517/17425247.2011.574125
- De Baere T, Ronot M, Chung JW, Golfieri R, Kloeckner R, Park J-W, et al. Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE). Cardiovasc Intervent Radiol 2022; 45: 1430-40. doi: 10.1007/s00270-022-03233-9
- Lewandowski RJ, Geschwind JF, Liapi E, Salem R. Transcatheter intraarterial therapies: rationale and overview. Radiology 2011; 259: 641-57. doi: 10.1148/radiol.11081489
- Akhlaghpoor S, Torkian P, Golzarian J. Transarterial bleomycin-lipiodol embolization (B/LE) for symptomatic giant hepatic hemangioma. Cardiovasc Intervent Radiol 2018; 41: 1674-82. doi: 10.1007/s00270-018-2010-4
- Fu J, Wang Y, Zhang J, Yuan K, Yan J, Yuan B, et al. The safety and efficacy of transarterial chemoembolisation with bleomycin for hepatocellular carcinoma unresponsive to doxorubicin: a prospective single-centre study. Clin Radiol 2021; 76: 864.e7-864.e12. doi: 10.1016/j.crad.2021.07.013
- Shimizu T, Nikaido T, Gomyo H, Yoshimura Y, Horiuchi A, Isobe K, et al. Electrochemotherapy for digital chondrosarcoma. J Orthop Sci 2003; 8: 248-51. doi: 10.1007/s007760300043
- Domenge C, Orlowski S, Luboinski B, Baere TD, Schwaab G, Belehradek J, et al. Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer 1996; 77: 956-63. doi: 10.1002/(SICI)1097-0142(19960301)77:5<;956::AID-CNCR23>3.0.CO;2-1
- Van Tilborg AAJM, Scheffer HJ, Van Der Meijs BB, Van Werkum MH, Melenhorst MCAM, Van Den Tol PM, et al. Transcatheter CT hepatic arteriography-guided percutaneous ablation to treat ablation site recurrences of colorectal liver etastases: the incomplete ring sign. J Vasc Interv Radiol 2015; 26: 583-7.e1. doi: 10.1016/j.jvir.2014.12.023
- Puijk RS, Nieuwenhuizen S, Van Den Bemd BAT, Ruarus AH, Geboers B, Vroomen LGPH, et al. Transcatheter CT hepatic arteriography compared with conventional CT fluoroscopy guidance in percutaneous thermal ablation to treat colorectal liver metastases: A single-center comparative analysis of 2 historical cohorts. J Vasc Intervent Radiol 2020; 31: 1772-83. doi: 10.1016/j.jvir.2020.05.011
- Puijk RS, Dijkstra M, Van Der Lei S, Schulz HH, Vos DJW, Timmer FEF, et al. The added value of transcatheter CT hepatic angiography (CTHA) image guidance in percutaneous thermal liver ablation: an experts’ opinion picto-rial essay. Cancers 2024;16: 1193. doi: 10.3390/cancers16061193
- Djokic M, Dezman R, Cemazar M, Stabuc M, Petric M, Smid LM, et al. Percutaneous image guided electrochemotherapy of hepatocellular car-cinoma: technological advancement. Radiol Oncol 2020; 54: 347-52. doi: 10.2478/raon-2020-0038
- Djokic M, Cemazar M, Popovic P, Kos B, Dezman R, Bosnjak M, et al. Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study. Eur J Surg Oncol 2018; 44: 651-7. doi: 10.1016/j.ejso.2018.01.090
- Tarantino L, Busto G, Nasto A, Fristachi R, Cacace L, Talamo M, et al. Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: a feasibility study. World J Gastroenterol 2017; 23: 906. doi: 10.3748/wjg.v23.i5.906
- Tarantino L, Busto G, Nasto A, Nasto RA, Tarantino P, Fristachi R, et al. Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: a feasibility study. Eur J Surg Oncol 2018; 44: 1603-9. doi: 10.1016/j. ejso.2018.06.025
- Luerken L, Doppler M, Brunner SM, Schlitt HJ, Uller W. Stereotactic percutaneous electrochemotherapy as primary approach for unresectable large HCC at the hepatic hilum. Cardiovasc Intervent Radiol 2021; 44: 1462-6. doi: 10.1007/s00270-021-02841-1
- Iezzi R, Posa A, Caputo CT, De Leoni D, Sbaraglia F, Rossi M, et al. Safety and feasibility of analgosedation for electrochemotherapy of liver lesions. Life 2023; 13: 631. doi: 10.3390/life13030631